Lonza Group (LZAGF.PK), a healthcare manufacturer, Wednesday reported profit before tax of CHF 754 million for the full year, lower than CHF 790 million in the previous year.
Net profit was CHF 636 million or CHF 8.92 per share compared with CHF 654 million or CHF 8.88 per share a year ago.
Excluding one-time items, core earnings increased to CHF 1.071 billion or CHF 15.01 per share from CHF 1.024 billion or CHF 13.88 per share last year.
EBITDA, or earnings before interest, taxes, depreciation, and amortization declined 12.6 percent to CHF 1.695 billion from CHF 1.940 billion a year ago.
Core EBITDA decreased 4.6 percent to CHF 1.908 billion from CHF 1.999 billion last year.
Sales for the year dropped to CHF 6.574 billion from CHF 6.717 billion in the previous year.
The company's Board has proposed a dividend of CHF 4 per share.
For comments and feedback: editorial@rttnews.com